Topical Squalamine 0.2% and Intravitreal Ranibizumab 0.5 mg as Combination Therapy for Macular Edema Due to Branch and Central Retinal Vein Occlusion An Open-Label, Randomized Stud...

von Wroblewski, John J
Veröffentlicht in: Ophthalmic surgery, lasers & imaging retina (2016)